Cell cycle inhibitors p21 and p16 are required for the regulation of Schwann cell proliferation

被引:41
作者
Atanasoski, S
Boller, D
De Ventura, L
Koegel, H
Boentert, M
Young, P
Werner, S
Suter, U [1 ]
机构
[1] ETH Honggerberg, Inst Cell Biol, Swiss Fed Inst Technol, Dept Biol, CH-8093 Zurich, Switzerland
[2] Univ Munster, Dept Neurol, D-4400 Munster, Germany
关键词
peripheral nerves; glia; development; nerve injury; cyclin-dependent kinase inhibitors;
D O I
10.1002/glia.20263
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Regulated cell proliferation is a crucial prerequisite for Schwann cells to achieve myelination in development and regeneration. In the present study, we have investigated the function of the cell cycle inhibitors p21. and p16 as potential regulators of Schwann cell proliferation, using p21- or p16-deficient mice. We report that both inhibitors are required for proper withdrawal of Schwann cells from the cell cycle during development and following injury. Postnatal Schwann cells express p21. exclusively in the cytoplasm, first detectable at postnatal day 7. This cytoplasmic p21. expression is necessary for proper Schwann cell proliferation control in the late development of peripheral nerves. After axonal damage, p21. is found in Schwann cell nuclei during the initiation of the proliferation period. This stage is critically regulated by p21, since loss of p21 leads to a strong increase in Schwann cell proliferation. Unexpectedly, p21. levels are upregulated in this phase suggesting that the role of p21. may be more complex than purely inhibitory for the Schwann cell cycle. However, inhibition of Schwann cell proliferation is the overriding crucial function of p21. and p16 in peripheral nerves as revealed by the consequences of loss-of-function in development and after injury. Different mechanisms appear to underlie the inhibitory function, depending on whether p21 is cytoplasmic or nuclear. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:147 / 157
页数:11
相关论文
共 35 条
[1]   Apoptosis inhibitory activity of cytoplasmic p21Cip1/WAF1 in monocytic differentiation [J].
Asada, M ;
Yamada, T ;
Ichijo, H ;
Delia, D ;
Miyazono, K ;
Fukumuro, K ;
Mizutani, S .
EMBO JOURNAL, 1999, 18 (05) :1223-1234
[2]   The protooncogene Ski Schwann cell proliferation controls and myelination [J].
Atanasoski, S ;
Notterpek, L ;
Lee, HY ;
Castagner, F ;
Young, P ;
Ehrengruber, MU ;
Meijer, D ;
Sommer, L ;
Stavnezer, E ;
Colmenares, C ;
Suter, U .
NEURON, 2004, 43 (04) :499-511
[3]   Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A [J].
Atanasoski, S ;
Scherer, SS ;
Nave, KA ;
Suter, U .
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 67 (04) :443-449
[4]   Differential cyclin D1 requirements of proliferating Schwann cells during development and after injury [J].
Atanasoski, S ;
Shumas, S ;
Dickson, C ;
Scherer, SS ;
Suter, U .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2001, 18 (06) :581-592
[5]  
Berger Alan R., 1995, P648
[6]   The p21Cip1 and p27Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts [J].
Cheng, MG ;
Olivier, P ;
Diehl, JA ;
Fero, M ;
Roussel, MF ;
Roberts, JM ;
Sherr, CJ .
EMBO JOURNAL, 1999, 18 (06) :1571-1583
[7]   MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL [J].
DENG, CX ;
ZHANG, PM ;
HARPER, JW ;
ELLEDGE, SJ ;
LEDER, P .
CELL, 1995, 82 (04) :675-684
[8]   Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control [J].
Di Cunto, F ;
Topley, G ;
Calautti, E ;
Hsiao, J ;
Ong, L ;
Seth, PK ;
Dotto, GP .
SCIENCE, 1998, 280 (5366) :1069-1072
[9]  
ELDEIRY WS, 1999, CANCER RES, V54, P1169
[10]   Ectopic p21WAF1 expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment [J].
Erhardt, JA ;
Pittman, RN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) :23517-23523